Accutane iPLEDGE Program Tops CDER Ombudsman’s 2006 Complaint List

The most frequent complaint to the Center for Drug Evaluation & Research Ombudsman's office in 2006 concerned implementation of the iPLEDGE program, the office said in its annual report, issued Feb. 28